These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2244814)

  • 21. Metastatic colorectal cancer: radioimmunoscintigraphy with a stabilized In-111-labeled F(ab')2 fragment of an anti-CEA monoclonal antibody.
    Lamki LM; Patt YZ; Rosenblum MG; Shanken LJ; Thompson LB; Schweighardt SA; Frincke JM; Murray JL
    Radiology; 1990 Jan; 174(1):147-51. PubMed ID: 2294542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy.
    Raderer M; Becherer A; Kurtaran A; Angelberger P; Li S; Leimer M; Weinlaender G; Kornek G; Kletter K; Scheithauer W; Virgolini I
    J Nucl Med; 1996 Sep; 37(9):1480-7. PubMed ID: 8790198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Indium 111-labeled antibodies in the detection of colorectal carcinoma].
    Artiko V; Obradović V; Davidović B; Petrović N; Petrović M; Krivokapić Z; Pavlov M; Adanja G; Sobić D; Vlajković M; Pavlović S; Rebić R
    Acta Chir Iugosl; 2003; 50(4):43-6. PubMed ID: 15307496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indium-labeled anti-colorectal carcinoma monoclonal antibody accumulation in non-tumored tissue in patients with colorectal carcinoma.
    Abdel-Nabi HH; Chan HW; Doerr RJ
    J Nucl Med; 1990 Dec; 31(12):1975-9. PubMed ID: 2266396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved tumor localization with increasing dose of indium-111-labeled anti-carcinoembryonic antigen monoclonal antibody ZCE-025 in metastatic colorectal cancer.
    Patt YZ; Lamki LM; Haynie TP; Unger MW; Rosenblum MG; Shirkhoda A; Murray JL
    J Clin Oncol; 1988 Aug; 6(8):1220-30. PubMed ID: 3045263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunoscintigraphy of colorectal cancer with 111In labeled anti-CEA monoclonal antibody (ZCE-025)].
    Katayama M; Nakamura K; Hashimoto T; Tsukatani Y; Fujii H; Hashimoto J; Kubo A; Hashimoto S; Teramoto T; Kodaira S
    Kaku Igaku; 1991 Sep; 28(9):1057-65. PubMed ID: 1770658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human biodistribution of 111In-labeled B72.3 monoclonal antibody.
    Harwood SJ; Carroll RG; Webster WB; Zangara LM; Laven DL; Morrissey MA; Sinni BJ
    Cancer Res; 1990 Feb; 50(3 Suppl):932s-936s. PubMed ID: 2297744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of radiolabelled monoclonal antibodies in patients with primary and metastatic large bowel cancer.
    Sergile SL; Haller DG; Daly JM
    Surg Oncol; 1992 Dec; 1(6):391-8. PubMed ID: 1341276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Planar, SPET and three-dimensional immunoscintigraphy of suspected recurrent colorectal cancer using 111In-B72.3 (Oncoscint CR-OV): effect of administered activity.
    Perkins AC; Vincent RM; Wastie ML; Denton GW; Amar S; Hardcastle JD
    Nucl Med Commun; 1994 Dec; 15(12):981-90. PubMed ID: 7715898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of primary lung cancer with indium 111 anti-carcinoembryonic antigen (type ZCE-025) monoclonal antibody scintigraphy.
    Krishnamurthy S; Morris JF; Antonovic R; Ahmed A; Galey WT; Duncan C; Krishnamurthy GT
    Cancer; 1990 Feb; 65(3):458-65. PubMed ID: 2297636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radioimmunodetection of colorectal carcinoma.
    Artiko V; Obradovic V; Davidovic B; Petrovic N; Petrovic M; Krivokapic Z; Kecmanovic D; Pesko P; Djukic V; Milosavljevic T; Adanja G; Vlajkovic M
    Hepatogastroenterology; 2003; 50(52):1029-31. PubMed ID: 12845972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative biodistributions of yttrium- and indium-labeled monoclonal antibody B72.3 in athymic mice bearing human colon carcinoma xenografts.
    Roselli M; Schlom J; Gansow OA; Raubitschek A; Mirzadeh S; Brechbiel MW; Colcher D
    J Nucl Med; 1989 May; 30(5):672-82. PubMed ID: 2785585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of radioimmunoscintigraphy and computed tomography scan prior to reassessment laparotomy of patients with ovarian carcinoma. A preliminary report.
    Method MW; Serafini AN; Averette HE; Rodriguez M; Penalver MA; Sevin BU
    Cancer; 1996 Jun; 77(11):2286-93. PubMed ID: 8635097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiolabeled antibody imaging in the management of colorectal cancer. Results of a multicenter clinical study.
    Doerr RJ; Abdel-Nabi H; Krag D; Mitchell E
    Ann Surg; 1991 Aug; 214(2):118-24. PubMed ID: 1867518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved detection of hepatic lesions using MoAb B72.3 and a modified 111In labelling technique in patients with recurrent colon cancer.
    Vijayakumar V; Blend MJ; Johnson DK; Seevers RH; Schnobrich KE; Bekerman C
    Nucl Med Commun; 1993 Aug; 14(8):658-66. PubMed ID: 8371891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma.
    Colcher D; Esteban J; Carrasquillo JA; Sugarbaker P; Reynolds JC; Bryant G; Larson SM; Schlom J
    Cancer Res; 1987 Aug; 47(15):4218-24. PubMed ID: 3607761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of radiolabeled antibody imaging on management of colon cancer.
    Beatty JD; Hyams DM; Morton BA; Beatty BG; Williams LE; Yamauchi D; Merchant B; Paxton RJ; Shively JE
    Am J Surg; 1989 Jan; 157(1):13-9. PubMed ID: 2910118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo fate of monoclonal antibody B72.3 in patients with colorectal cancer.
    Colcher D; Milenic DE; Ferroni P; Carrasquillo JA; Reynolds JC; Roselli M; Larson SM; Schlom J
    J Nucl Med; 1990 Jul; 31(7):1133-42. PubMed ID: 2362192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
    Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
    Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indium-111-labeled B72.3 monoclonal antibody in the detection and staging of breast cancer: a phase I study.
    Lamki LM; Buzdar AU; Singletary SE; Rosenblum MG; Bhadkamkar V; Esparza L; Podoloff DA; Zukiwski A; Hortobagyi GN; Murray JL
    J Nucl Med; 1991 Jul; 32(7):1326-32. PubMed ID: 2066785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.